mega pharma deal: dilip shanghvi & israel makov ivu seg 3
Published 10 years ago • 3.8K plays • Length 13:03Download video MP4
Download video MP3
Similar videos
-
11:13
can divest good assets asap: sun pharma chairman, israel makov
-
4:45
google has a 'big cost advantage' over microsoft azure, says d.a. davidson's gil luria
-
21:50
looking at acquisitions that add value, says sun pharma’s israel makov | what's hot | cnbc tv18
-
1:46
sun pharma q2fy25 earnings today: high single-digit growth in domestic formulations likely
-
1:11
expect to meet the guidance this year: sun pharma
-
11:34
breaking: south africa isn't backing down! - takes israel back to the icj!
-
3:27
israeli economy projected to incur losses of $100b by 2025
-
24:24
iranian nuclear facilities could be next | jerusalem dateline - october 29, 2024
-
2:39
dilip shanghvi says pricing pressure to continue in the market | cnbc tv18
-
3:18
the zionist regime has miscalculated iran: warns iran's supreme leader | n18g | cnbc tv18
-
14:07
forbes india leadership awards 2014 - seg 1: dilip shanghvi, sun pharma - oct 13
-
10:11
dilip shanghvi has lost nearly a third of his wealth in 2018
-
2:43
dilip shanghvi's expansion plans
-
1:00
why israel’s war against hamas is costing its economy
-
7:26
growth has been good in the us mkt; expect topline data on psoriatic arthritis by fy25: sun pharma
-
10:57
sun pharma row : dilip shanghvi assured investors of highest level of corporate governance
-
3:34
dilip shanghvi interview: specialty biz will drive growth; expect transactions to continue in pharma
-
3:13
innovation: dilip shanghvi's mantra
-
17:54
halftime report: sun pharma-ranbaxy merger fineprint - mar 25
-
5:38
google search benefiting from generative ai, says deepwater's gene munster
-
0:32
top 5 pharma sector company in india | best stock #shorts #youtubeshorts
-
1:44
sun pharma q2 earnings: net profit at ₹3,040 cr, beats estimates | cnbc tv18